1. Home
  2. MNKD vs NMM Comparison

MNKD vs NMM Comparison

Compare MNKD & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NMM
  • Stock Information
  • Founded
  • MNKD 1991
  • NMM 2007
  • Country
  • MNKD United States
  • NMM Monaco
  • Employees
  • MNKD N/A
  • NMM N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NMM Marine Transportation
  • Sector
  • MNKD Health Care
  • NMM Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • NMM Nasdaq
  • Market Cap
  • MNKD 1.8B
  • NMM 1.4B
  • IPO Year
  • MNKD 2004
  • NMM 2007
  • Fundamental
  • Price
  • MNKD $6.22
  • NMM $43.25
  • Analyst Decision
  • MNKD Strong Buy
  • NMM Strong Buy
  • Analyst Count
  • MNKD 5
  • NMM 1
  • Target Price
  • MNKD $8.40
  • NMM $80.00
  • AVG Volume (30 Days)
  • MNKD 2.8M
  • NMM 183.6K
  • Earning Date
  • MNKD 11-07-2024
  • NMM 02-11-2025
  • Dividend Yield
  • MNKD N/A
  • NMM 0.46%
  • EPS Growth
  • MNKD N/A
  • NMM N/A
  • EPS
  • MNKD 0.08
  • NMM 13.27
  • Revenue
  • MNKD $267,200,000.00
  • NMM $1,328,798,000.00
  • Revenue This Year
  • MNKD $45.36
  • NMM N/A
  • Revenue Next Year
  • MNKD $16.99
  • NMM $15.76
  • P/E Ratio
  • MNKD $74.80
  • NMM $3.30
  • Revenue Growth
  • MNKD 51.35
  • NMM N/A
  • 52 Week Low
  • MNKD $3.17
  • NMM $26.81
  • 52 Week High
  • MNKD $7.63
  • NMM $65.89
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.90
  • NMM 25.90
  • Support Level
  • MNKD $5.81
  • NMM $42.19
  • Resistance Level
  • MNKD $6.77
  • NMM $44.55
  • Average True Range (ATR)
  • MNKD 0.25
  • NMM 1.34
  • MACD
  • MNKD -0.07
  • NMM -0.29
  • Stochastic Oscillator
  • MNKD 36.44
  • NMM 16.62

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests

Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.

Share on Social Networks: